Terapevticheskii arkhivTerapevticheskii arkhiv0040-36602309-5342LLC Obyedinennaya Redaktsiya3231610.17116/terarkh201789880-87Research ArticleThe Russian consensus on the diagnosis and treatment of chronic pancreatitis: Enzyme replacement therapyKhatkovI E-MaevI V-BordinD S-KucheryavyiYu A-AbdulkhakovS R-AlekseenkoS A-AlievaE I-AlikhanovR B-BakulinI G-BaranovskyA Yu-BeloborodovaE V-BelousovaE A-BurievI M-BystrovskayaE V-VertyankinS V-VinokurovaL V-GalperinE I-GorelovA V-GrinevichV B-DanilovM V-DarvinV V-DubtsovaE A-DyuzhevaT G-EgorovV I-EfanovM G-ZakharovaN V-ZagainovV E-IvashkinV T-IzrailovR E-KorochanskayaN V-KornienkoE A-KorobkaV L-KokhanenkoN Yu-LivzanM A-LoranskayaI D-NikolskayaK A-OsipenkoM F-OkhlobystinA V-PasechnikovV D-PlotnikovaE Yu-PolyakovaS I-SablinO A-SimanenkovV I-UrsovaN I-TsvirkunV V-TsukanovV V-ShabuninA V-15082017898808710042020Copyright © 2017, Consilium Medicum2017Pancreatology Club Professional Medical Community, 1A.S. Loginov Moscow Clinical Research and Practical Center, Moscow Healthcare Department, Moscow; 2A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow; 3Kazan State Medical University, Ministry of Health of Russia, Kazan; 4Kazan (Volga) Federal University, Kazan; 5Far Eastern State Medical University, Ministry of Health of Russia, Khabarovsk; 6Morozov City Children’s Clinical Hospital, Moscow Healthcare Department, Moscow; 7I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia, Saint Petersburg; 8Siberian State Medical University, Ministry of Health of Russia, Tomsk; 9M.F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow; 10Maimonides State Classical Academy, Moscow; 11V.I. Razumovsky State Medical University, Ministry of Health of Russia, Saratov; 12I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow; 13S.M. Kirov Military Medical Academy, Ministry of Defense of Russia, Saint Petersburg; 14Surgut State Medical University, Ministry of Health of Russia, Surgut; 15City Clinical Hospital Five, Moscow Healthcare Department, Moscow; 16Nizhny Novgorod Medical Academy, Ministry of Health of Russia, Nizhny Novgorod; 17Territorial Clinical Hospital Two, Ministry of Health of the Krasnodar Territory, Krasnodar; 18Saint Petersburg State Pediatric Medical University, Ministry of Health of Russia, Saint Petersburg; 19Rostov State Medical University, Ministry of Health of Russia, Rostov-on-Don; 20Omsk Medical University, Ministry of Health of Russia, Omsk; 21Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, Moscow; 22Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk; 23Stavropol State Medical University, Ministry of Health of Russia, Stavropol; 24Kemerovo State Medical University, Ministry of Health of Russia, Kemerovo; 25N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow; 26A.M. Nikiforov All-Russian Center of Emergency and Radiation Medicine, Russian Ministry for Civil Defense, Emergencies and Elimination of Consequences of Natural Disasters, Saint Petersburg; 27Research Institute for Medical Problems of the North, Siberian Branch, Russian Academy of Sciences, Krasnoyarsk; 28S.P. Botkin City Clinical Hospital, Moscow Healthcare Department, Moscow; 29Tver State Medical University, Ministry of Health of Russia, Tver The Russian consensus on the diagnosis and treatment of chronic pancreatitis has been prepared on the initiative of the Russian Pancreatology Club to clarify and consolidate the opinions of Russian specialists (gastroenterologists, surgeons, and pediatricians) on the most significant problems of diagnosis and treatment of chronic pancreatitis. This article continues a series of publications explaining the most significant interdisciplinary consensus statements and deals with enzyme replacement therapy.Russian consensusdiagnosistreatmentchronic pancreatitisenzyme replacement therapyРоссийский консенсусдиагностикалечение хронический панкреатитзаместительная ферментная терапия[Linstone H, Turoff M. The Delphi method: Techniques and applications. URL: http://www.is.njit.edu/pubs/delphibook/][Хатьков И.Е., Маев И.В., Абдулхаков С.Р. и др. Российский консенсус по диагностике и лечению хронического панкреатита. Терапевтическийархив. 2017;2:105-113. https://doi.org/10.17116/terarkh2017892105-113][Хатьков И.Е., Маев И.В., Бордин Д.С., Кучерявый Ю.А. и др. Российский консенсус по диагностике и лечению хронического панкреатита: акцент на нутритивный статус и вопросы питания. Фарматека. 2016;S5-16:27-32.][Хатьков И.Е., Маев И.В., Бордин Д.С., Кучерявый Ю.А. и др. Спорные вопросы Российского консенсуса по диагностике и лечению хронического панкреатита. Альманах клин. медицины. 2016;44(6):654-660.][Хатьков И.Е., Маев И.В., Бордин Д.С., Кучерявый Ю.А. и соавт. Российский консенсус по диагностике и лечению хронического панкреатита: лечение абдоминальной боли. Доктор.Ру. 2017;2(131):38-45.][Рекомендации Научного общества гастроэнтерологов России по диагностике и лечению хронического панкреатита (приняты 11 съездом НОГР 2 марта 2011 г. на заседании Российского панкреатического клуба). Экспериментальная и клиническая гастроэнтерология 2011;7:122-129.][Маев И.В., Кучерявый Ю.А., Андреев Д.Н., Бидеева Т.В. Статус питания больных хроническим панкреатитом. Терапевтическийархив. 2016;88(2):81-89. https://doi.org/10.17116/terarkh201688281-89][Hart PA, Conwell DL. Diagnosis of Exocrine Pancreatic Insufficiency. Curr Treat Options Gastroenterol. 2015;13(3):347-353. https://doi.org/10.1007/s11938-015-0057-8][Dumasy V, Delhaye M, Cotton F, Deviere J. Fat malabsorption screening in chronic pancreatitis. Am J Gastroenterology. 2004;99: 1350-1354. https://doi.org/10.1111/j.1572-0241.2004.30661.x][Bornman PC, Botha JF, Ramos JM et al. Guideline for the diagnosis and treatment of chronic pancreatitis. S Afr Med J. 2010; 100(12 Pt 2):845-860.][Conwell DL, Lee LS, Yadav D et al. Daniel S. American Pancreatic Association Practice Guidelines in Chronic Pancreatitis Evidence-Based Report on Diagnostic Guidelines. Pancreas. 2014;43(8):1143-1162 https://doi.org/10.1097/MPA.0000000000000237][Trang T, Chan J, Graham DY. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21st century. World J Gastroenterol. 2014;20(33):11467-11485. https://doi.org/10.3748/wjg.v20.i33.11467][Afghani E1, Sinha A, Singh VK. An overview of the diagnosis and management of nutrition in chronic pancreatitis. Nutr Clin Pract. 2014;29(3):295-311. https://doi.org/10.1177/0884533614529996][Toouli J, Biankin AV, Oliver MR, Pearce CB, Wilson JS, Wray NH. Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club recommendations. Med J Aust. 2010; 193:461-467.][Löhr JM, Oliver MR, Frulloni L. Synopsis of recent guidelines on pancreatic exocrine insufficiency. United European Gastroenterology Journal. 1(2):79-83. https://doi.org/10.1177/2050640613476500][Domínguez-Muñoz JE, Iglesias-Garcia J, Vilarino-Insua M, et al. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2007;5:484-488. https://doi.org/10.1016/j.cgh.2007.01.004][Lindkvist B, Phillips ME, Domínguez-Muñoz JE. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use. Pancreatology. 2015;15(6):589-597. https://doi.org/10.1016/j.pan.2015.07.001][De-Madaria E, Abad-González A, Aparicio JR. et al. The Spanish Pancreatic Club’s recommendations for the diagnosis and treatment of chronic pancreatitis: part 2 (treatment). Pancreatology. 2013;13:18-28. https://doi.org/10.1016/j.pan.2012.11.310][Маев И.В., Кучерявый Ю.А. Заместительная ферментная терапия при панкреатической недостаточности. Клинические перспективы гастроэнтерологии, гепатологии. 2005;5:19-28.][Ивашкин В.Т., Маев И.В., Охлобыстин А.В., Кучерявый Ю.А., Трухманов А.С., Шептулин А.А. и соавт. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению хронического панкреатита. Российский журнал гастроэнтерологии, гепатологии, колопрокологии. 2014;4:70-97.][Hoffmeister A, Mayerle J, Beglinger C, Buchler MW, Bufler P, Dathe K, Folsch UR, Friess H, Izbicki J, Kahl S, Klar E, Keller J, Knoefel WT, Layer P, Loehr M, Meier R, Riemann JF, Runzi M, Schmid RM, Schreyer A, Tribl B, Werner J, Witt H, Mossner J, Lerch M. S3-Leitlinie Chronische Pankreatitis: Definition, Atiologie, Diagnostik, konservative, interventionell endoskopische und operative Therapie der chronischen Pankreatitis. Leitlinie der Deutschen Gesellschaft fur Verdauungsund Stoffwechselkrankheiten (DGVS). Z Gastroenterol. 2012;50(11):1176-1224. https://doi.org/10.1055/s-0032-1325479][Frulloni L, Falconi M, Gabbrielli A, Gaia E, et al. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis. 2010;42(Suppl.6): S381-406. https://doi.org/10.1016/S1590-8658(10)60682-2][Halm U, Löser C, Löhr M, et al. A double-blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency. Aliment Pharmacol Ther. 1999;13(7):951-957.][Domínguez-Muñoz JE. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep. 2007;9:116-122.][Bruno MJ, Rauws EA, Hoek FJ, Tytgat GN. Comparative effects of adjuvant cimetidine and omeprazole during pancreatic enzyme replacement therapy. Dig Dis Sci. 1994;39(5):988-992.][Sander-Struckmeier S, Beckmann K, Janssen-van Solingen G, Pollack P. Retrospective analysis to investigate the effect of concomitant use of gastric acid-suppressing drugs on the efficacy and safety of pancrelipase/pancreatin (CREON) in patients with pancreatic exocrine insufficiency. Pancreas. 2013;42(6):983-989. https://doi.org/10.1097/MPA.0b013e31828784ef][Vecht J, Symersky T, Lamers CB, Masclee AA. Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency. J Clin Gastroenterol. 2006;40:721-725.][Domínguez-Muñoz JE. Chronic pancreatitis and persistent steatorrhea: what is the correct dose of enzymes? Clin Gastroenterol Hepatol. 2011;9(7):541-546. https://doi.org/10.1016/j.cgh.2011.02.027][Lerch MM, Pezzilli R, Vasileva G, Pap A, Varga M, Friess H. Randomised clinical trial: a 1-week, double-blind, placebocontrolled study of pancreatin 25 000 Ph. Eur. Minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension. Aliment Pharmacol Ther. 2013;37(7):691-702. https://doi.org/10.1111/apt.12236][Sikkens EC, Cahen DL, Kuipers EJ, Bruno MJ. Pancreatic enzyme replacement therapy in chronic pancreatitis. BestPractResClinGastroenterol. 2010;24(3):337-347. https://doi.org/10.1016/j.bpg.2010.03.006][Бордин Д., Винокурова Л., Дубцова Е., Осипенко Ю. Хронический панкреатит и синдром избыточного бактериального роста. Врач. 2011;13:5-10.][Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future. Clin Exp Gastroenterol. 2011;4:55-73. https://doi.org/10.2147/CEG.S17634][Quian Z, Fields CJ, Yu Y, Lutz S. Recent progress in engineering alpha/beta hydrolase-fold family members. Biotechnol J. 2007; 2(2):192-200.][Gheorghe C, Seicean A, Saftoiu A, Tantau M, Dumitru E, Jinga M, Negreanu L, Mateescu B, Gheorghe L, Ciocirlan M, Cijevschi C, Constantinescu G, Dima S, Diculescu M. Romanian Guidelines on the Diagnosis and Treatment of Exocrine Pancreatic Insufficiency. J Gastrointestin Liver Dis. 2015;24(1):117-123. https://doi.org/10.15403/jgld.2014.1121.app][Ramesh H, Reddy N, Bhatia S, etal. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Pancreatology. 2013;13:133-139. https://doi.org/10.1016/j.pan.2013.01.009][Whitcomb DC, Lehman GA, Vasileva G et al. Pancrelipase delayedrelease capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. Am J Gastroenterol. 2010;105:2276-2286. https://doi.org/10.1038/ajg.2010.201][Somaraju UR, Solis-Moya A. Pancreatic enzyme replacement therapy for people with cystic fibrosis. Cochrane Database Syst Rev. 2014;10:CD008227. https://doi.org/10.1002/14651858.CD008227.pub2][Pezzilli R, Andriulli A, Bassi C, Balzano G, Cantore M, Delle Fave G, Falconi M, Frulloni L. Exocrine pancreatic insufficiency in adults: A shared position statement of the Italian association for the study of the pancreas; the Exocrine Pancreatic Insufficiency collaborative (EPIc) Group. World J Gastroenterol. 2013;19(44): 7930-7946. https://doi.org/10.3748/wjg.v19.i44.7930][Bansi DS, Price A, Russell C, Sarner M. Fibrosing colonopathy in an adult owing to over use of pancreatic enzyme supplements. Gut. 2000;46(2):283-285.][Prescott P, Bakowski MT. Pathogenesis of fibrosing colonopathy: the role of methacrylic acid copolymer. Pharmacoepidemiol Drug Saf. 1999;8(6):377-384. https://doi.org/10.1002/(SICI)1099-1557(199910/11)8:6<377:: AID-PDS448>3.0.CO;2-C][Sack J, Blau H, Goldfarb D, Ben-Zaray S, Katznelson D. Hyperuricosuria in cystic fibrosis patients treated with pancreatic enzyme supplements. A study of 16 patients in Israel. Isr J Med Sci. 1980;16:417-419.][Ewald N, Kaufmann C, Raspe A, et al. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev. 2012;28(4):338-342. https://doi.org/10.1002/dmrr.2260][Weitgasser R, Abrahamian H, Clodi M, Fortunat W, Hammer H. Position paper: Exocrine pancreatic insufficiency and diabetes mellitus. Wien Klin Wochenschr. 2012;124(Suppl.2):100-103. https://doi.org/10.1007/s00508-012-0290-2][Маев И.В., Кучерявый Ю.А., Москалева А.Б. Хронический панкреатит: мифы и реалии. Фарматека. 2010;12:24-31.][Frulloni L, Falconi M, Gabbrielli A et al. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis. 2010;42(suppl.6):381-406. https://doi.org/10.1016/S1590-8658(10)60682-2]